Is yearly intravenous zoledronic acid comparable to weekly oral alendronate for postmenopausal osteoporosis?
Brandi
Maria Luisa
ML
Department of Internal Medicine at the University of Florence, Florence, Italy. m.brandi@dmi.unifi.it